Preferential enlargement of leukemia cells using cytoskeletal-directed agents and cell cycle growth control parameters to induce sensitivity to low frequency ultrasound

Cancer Letters

Volumn 360, Issue 2, 2015, Pages 160-170

  Trendowski, Matthew ^a   Wong, Victoria ^a   Zoino, Joseph N ^a   Christen, Timothy D ^a   Gadeberg, Lauren ^b   Sansky, Michelle ^c   Fondy, Thomas P ^a  

^a SYRACUSE UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^c EASTERN MAINE MEDICAL CENTER   (United States)

Author keywords

Cell cycle synchronization; Chemotherapy; Cytoskeletal directed agents; Leukemia; Sonodynamic therapy; Ultrasound

Indexed keywords

CYTOCHALASIN B; JASPAMIDE; PACLITAXEL; VINCRISTINE; ANTINEOPLASTIC AGENT; CULTURE MEDIUM; DEPSIPEPTIDE;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE PROGRESSION; CELL DAMAGE; CELL DISRUPTION; CELL ENLARGEMENT; CELL PROLIFERATION; CELL SIZE; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; LEUKEMIA CELL; MICROFILAMENT; MICROTUBULE; PHYSICAL SENSITIVITY; PRIORITY JOURNAL; SONODYNAMIC THERAPY; ULTRASONIC SENSITIVITY; ULTRASOUND THERAPY; ANIMAL; CELL CYCLE; CELL DEATH; CELL GROWTH; CULTURE MEDIUM; CYTOSKELETON; DRUG EFFECTS; ECHOGRAPHY; LEUKEMIA; LEUKEMIA L1210; MOUSE; PATHOLOGY; PHYSIOLOGY; U937 CELL LINE;

MURINAE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DEATH; CELL GROWTH PROCESSES; CULTURE MEDIA, SERUM-FREE; CYTOCHALASIN B; CYTOSKELETON; DEPSIPEPTIDES; HUMANS; LEUKEMIA; LEUKEMIA L1210; MICE; MICROTUBULES; PACLITAXEL; U937 CELLS; ULTRASONIC THERAPY; VINCRISTINE;

EID: 84924910410     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.001     Document Type: Article

References (30)

1. Kuroki M., Hachimine K., Abe H., Shibaguchi H., Kuroki M., Maekawa S., et al. Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res 2007, 27(6A):3673-3677.
2. Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrason. Sonochem 2004, 11(6):349-363.
3. Trendowski M. The promise of sonodynamic therapy. Cancer Metastasis Rev 2014, 33(1):143-160.
4. Ando H., Feril L.B., Kondo T., Tabuchi Y., Ogawa R., Zhao Q.L., et al. An echo-contrast agent, levovist, lowers the ultrasound intensity required to induce apoptosis of human leukemia cells. Cancer Lett 2006, 241(1):37-45.
5. Masui T., Ota I., Kanno M., Yane K., Hosoi H. Low-intensity ultrasound enhances the anticancer activity of cetuximab in human head and neck cancer cells. Exp. Ther. Med 2013, 5(1):11-16.
6. Skorpíková J., Dolníková M., Hrazdira I., Janisch R. Changes in microtubules and microfilaments due to a combined effect of ultrasound and cytostatics in hela cells. Folia Biol 2001, 47(4):143-147.
7. Todorova M., Agache V., Mortazavi O., Chen B., Karshafian R., Hynynen K., et al. Antitumor effects of combining metronomic chemotherapy with the antivascular action of ultrasound stimulates microbubbles. Int. J. Cancer 2013, 132(12):2956-2966.
8. Meng Q., Chen B., Wu W., Shao Z., Gao F., Zhao H. Enhanced antitumor effects of low-frequency ultrasound combined with adriamycin on human leukemia multidrug resistance cell line K562/A02. Chin. J. Cancer 2008, 27(11):436-439.
9. Tinkov S., Coester C., Serba S., Geis N.A., Katus H.A., Winter G., et al. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J. Control. Release 2010, 148(3):368-372.
10. Trendowski M., Yu G., Wong V., Acquafondata C., Christen T., Fondy T.P. The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells. Anticancer Res 2014, 34:2195-2202.
11. Zhai B., Chen L., Guo Y., Wang Z., Wu F. Experimental study of ultrasound on MDR in a human tumor in vivo. Chin. J. Clin. Oncol 2007, 4(6):390-396.
12. Bousquet P.F., Paulsen L.A., Fondy C., Lipski K.M., Loucy K.J., Fondy T.P. Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma. Cancer Res 1990, 50(5):1431-1439.
13. de Witte T., Suciu S., Verhoef G., Labar B., Archimbaud E., Aul C., et al. Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood 2001, 98(8):2326-2331.
14. Dietrich S., Weidle J., Rieger M., Meissner J., Radujkovic A., Ho A.D., et al. Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma. Leukemia 2014, 28(3):708-709.
15. Jackson D.V., Chauvenet A.R., Callahan R.D., Atkins J.N., Trahey T.F., Spurr C.L. Phase II trial of vincristine infusion in acute leukemia. Cancer Chemother. Pharmacol 1985, 14(1):26-29.
16. Rueda D.A., Márquez A., Gumá J., Llanos M., Herrero J., de Las Nieves M.A., et al. Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study. Ann. Oncol 2004, 15(12):1798-1804.
17. Weinberg R.A. The Biology of Cancer 2013, Garland Science, New York, NY. second ed.
18. Bai W., Shen E., Hu B. Induction of the apoptosis of cancer cell by sonodynamic therapy: a review. Chin. J. Cancer Res 2012, 24(4):368-373.
19. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discov 2005, 4(3):255-260.
20. Ashush H., Rozenszajn L.A., Blass M., Barda-Saad M., Azimov D., Radnay J., et al. Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res 2000, 60(4):1014-1020.
21. Trendowski M., Wong V., Yu G., Fondy T.P. Enlargement and multinucleation of U937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents. Anticancer Res 2015, 35(1):65-76.
22. Lagneaux L., Cordemans de Meulenaer E., Delforge A., Dejeneffe M., Massy M., Moerman C., et al. Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Exp. Hematol 2002, 30(11):1293-1301.
23. Honda H., Kondo T., Zhao Q., Feril L.B., Kitatgawa H. Role of intracellular calcium ions and reactive oxygen species in apoptosis induced by ultrasound. Ultrasound Med. Biol 2004, 30(5):683-692.
24. Yoshida T., Kondo T., Ogawa R., Feril L.B., Zhao Q.L., Watanabe A., et al. Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells. Cancer Chemother. Pharmacol 2008, 61(4):559-567.
25. Trendowski M. The inherent metastasis of leukaemia and its exploitation by sonodynamic therapy. Crit. Rev. Oncol. Hematol 2015, In press.
26. Kolber M.A., Hill P. Vincristine potentiates cytochalasin B-induced DNA fragmentation in vitro. Cancer Chemother. Pharmacol 1992, 30(4):286-290.
27. Tsuru H., Shibaguchi H., Kuroki M., Yamashita Y., Kuroki M. Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer. Free Radic. Biol Med 2012, 53(3):464-472.
28. Zhao Y., Lu C., Zhou Z., Jin Z., Sun C., Xu Y., et al. Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment. J. Drug Target 2011, 19(2):154-160.
29. Goertz D.E., Todorova M., Mortazavi O., Agache V., Chen B., Karshafian R., et al. Antitumor effects of combining docetaxel (taxotere) with the antivascular action of ultrasound stimulated microbubbles. PLoS ONE 2012, 7(12):e52307.
30. Sazgarnia A., Shanei A., Meibodi N.T., Eshghi H., Nassirli H. A novel nanosonosensitizer for sonodynamic therapy: in vivo study on a colon tumor model. J. Ultrasound Med 2011, 30(10):1321-1329.